Günter Burg

Vaccination of melanoma patients with peptide- or tumorlysate-pulsed dendritic cells

Frank O. Nestlé, Selma Alijagic, Michel Gilliet et al. · Nature Medicine · 1998 · 2.9K citations

Vaccination, Tumor Immunology, Cancer Immunosurveillance +7

Revisions to the staging and classification of mycosis fungoides and Sézary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the cutaneous lymphoma task force of the European Organization of Research and Treatment of Cancer (EORTC)

Elise A. Olsen, Eric C. Vonderheid, Nicola Pimpinelli et al. · Blood · 2007 · 1.4K citations

Plasmacytoid predendritic cells initiate psoriasis through interferon-α production

Frank O. Nestlé, Curdin Conrad, Adrian Tun-Kyi et al. · The Journal of Experimental Medicine · 2005 · 1.1K citations · Full text

Clinical End Points and Response Criteria in Mycosis Fungoides and Sézary Syndrome: A Consensus Statement of the International Society for Cutaneous Lymphomas, the United States Cutaneous Lymphoma Consortium, and the Cutaneous Lymphoma Task Force of the European Organisation for Research and Treatment of Cancer

Elise A. Olsen, Sean Whittaker, Youn H. Kim et al. · Journal of Clinical Oncology · 2011 · 641 citations · Full text

Immunodeficiencies, Immunology, Clinical End Points +17

Dacarbazine (DTIC) versus vaccination with autologous peptide-pulsed dendritic cells (DC) in first-line treatment of patients with metastatic melanoma: a randomized phase III trial of the DC study group of the DeCOG

Dirk Schadendorf, Selma Ugurel, Beatrice Schuler‐Thurner et al. · Annals of Oncology · 2006 · 466 citations · Full text

Cancer Immunosurveillance, Medicine, Melanoma +9